Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
McCarthy NS, Vangjeli C, Surendran P, Treumann A, Rooney C, Ho E, Sever P, Thom S, Hughes AD, Munroe PB, Howard P, Johnson T, Caulfield M, Shields DC, O'Brien E, Fitzgerald DJ, Stanton AV.
McCarthy NS, et al. Among authors: treumann a.
Atherosclerosis. 2018 Feb;269:42-49. doi: 10.1016/j.atherosclerosis.2017.12.013. Epub 2017 Dec 8.
Atherosclerosis. 2018.
PMID: 29258006
Free PMC article.